Coherus BioSciences
CHRS
#8258
Rank
ยฃ0.18 B
Marketcap
ยฃ1.50
Share price
-3.74%
Change (1 day)
59.29%
Change (1 year)

Coherus BioSciences (CHRS) Fails to deliver data

Key failure to deliver metrics for Coherus BioSciences :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Coherus BioSciences (CHRS) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Coherus BioSciences (CHRS) - since 2014

Volume in USD (price x number of shares), data since 2014

Coherus BioSciences (CHRS) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2026ยฃ0.32 M-92.51%
2025ยฃ4.4 M-13.23%
2024ยฃ5.07 M-66.46%
2023ยฃ15.13 M203.14%
2022ยฃ4.99 M-3.35%
2021ยฃ5.16 M-85.14%
2020ยฃ34.75 M659.1%
2019ยฃ4.57 M-79.64%
2018ยฃ22.49 M-5.08%
2017ยฃ23.69 M25.31%
2016ยฃ18.91 M-5.73%
2015ยฃ20.06 M5426.91%
2014ยฃ0.36 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Amgen
AMGN
ยฃ0.20 Bยฃ0.37 B๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
ยฃ6.47 Mยฃ21.79 M๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
N/Aยฃ0.01 M๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
N/Aยฃ0.21 B๐Ÿ‡บ๐Ÿ‡ธ USA